Table 1.
Characteristics of breast cancer patients who desired to undergo ovarian tissue cryopreservation
| No. | Age (years old) | Marital Status | Past pregnancies | BMI | Phase of mentruation (Day) | AMH (ng/ml) | No. of oocytes | No. of ovarian tissues | Procedure of laparoscopy | Molecular subtype | Pretreatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 34 | Single | None | 23.7 | F (6) | 4.2 | 17 | 18 | Multiple | A | |
| 2 | 33 | Married | None | 25 | L (22) | 6.90 | 11 | 12 | Multiple | B | FEC*4 DOC/HCN*4 |
| 3 | 32 | Single | None | 19 | F (6) | 3.16 | 12 | 28 | Multiple | B | |
| 4 | 39 | Single | None | 20.8 | F (3) | 3.98 | 5 | 16 | Multiple | A | Radiation |
| 5 | 39 | Married | None | 19.2 | F (4) | 1.57 | 4 | 18 | Multiple | B | |
| 6 | 29 | Married | None | 23.1 | F (3) | 5.82 | 19 | 26 | Multiple | B | |
| 7 | 33 | Married | 1G1P | 30.6 | F (7) | 3.06 | 2 | 16 | Multiple | B | |
| 8 | 30 | Single | None | 23.8 | L (22) | 6.62 | 7 | 15 | Multiple | B | |
| 9 | 36 | Single | None | 201 | F (6) | 1.37 | 7 | 17 | Multiple | B | GnRHa 2y, TAM 5y |
| 10 | 41 | Married | 1G0P | 32.8 | L (17) | 0.72 | 4 | 9 | Multiple | B | |
| 11 | 36 | Single | 1G0P | 18.2 | unknown | 1.45 | 5 | 20 | Multiple | B | |
| 12 | 35 | Single | None | 19.4 | F (7) | 0.87 | 0 | 22 | Multiple | B | |
| 13 | 33 | Single | None | 19.7 | L (28) | 6.13 | 26 | 23 | Multiple | B | |
| 14 | 33 | Single | None | 19.9 | L (25) | 2.05 | 9 | 18 | Multiple | A | |
| 15 | 34 | Married | None | 18.9 | F (9) | 1.09 | 0 | 20 | Multiple | B | CE*4 DOC/HCN*4 |
| 16 | 32 | Single | None | 19.5 | F (8) | 4.35 | 14 | 17 | Multiple | HER2 | |
| 17 | 34 | Single | None | 20.1 | L (16) | 2.21 | 6 | 12 | Single | Tri neg | |
| 18 | 37 | Married | None | 17.7 | L (25) | 0.7 | 2 | 15 | Single | A | TAM 2 M |
| 19 | 36 | Married | 1G0P | 23.9 | L (32) | 3.03 | 10 | 6 | Single | B | |
| 20 | 29 | Single | None | 19.6 | unknown | 5.2 | 6 | 19 | Single | B | |
| 21 | 33 | Married | 3G0P | 20.2 | F (14) | 5.31 | 9 | 17 | Single | B | surgery |
| 22 | 38 | Married | 1G0P | 24.5 | F (8) | 0.52 | 10 | 8 | Single | B | |
| 23 | 34 | Single | None | 21.1 | F (13) | 3.56 | 2 | 11 | Single | A | |
| 24 | 36 | Single | None | 22.3 | L (23) | 3.82 | 5 | 14 | Single | B | |
| 25 | 34 | Single | None | 18.6 | F (3) | 5.51 | 9 | 14 | Single | B | |
| 26 | 25 | Single | None | 17.6 | F (6) | 7.73 | 17 | 14 | Single | B | |
| 27 | 25 | Single | 1G0P | 19 | L (29) | 2.54 | 8 | 16 | Single | B |
F Follicular phase, L Luteal phase, Multiple multiple port surgery, Single Single port laparoscopy, A Luminal A type, B Luminal B type, Tri neg triple negative type, TAM tamoxifen, FEC 5-FU and epirubicin and cyclophosphamide, DOC docetaxel, HCN trastuzumab, CE cyclophosphamide and epirubicin, GnRHa gonadotropin releasing hormone agonist